The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change-21.5% to $23.10
Predicted High$30.20at 1 month
Predicted Low$23.10at 6 months
Max Drawdown (predicted)-21.5%
Forecast
The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded.
Predicted Sep 5, 2026 1:07 pm
Bear
DOW trends lower to
$23.10
(-21.5% from $29.44)
by Mar 2027.
ride-then-fade
ThesisDOW trades well above every fair-value anchor with negative quality and value scores, but a fragile turnaround narrative, risk-on regime, and back-to-back EPS beats offer near-term support. Expect a modest bounce into the October print, then gradual gravity toward the deterministic baseline as chemical fundamentals reassert.
Invalidated ifA clean Q3 beat with raised guidance holding price above $31, or conversely a break below $24 pre-earnings, would falsify the drift path.
Checkpointtime after the call
Datewhen it gets graded
Predictedthe claim: closing price
Current priceactual close — fills in over time
Predicted returnpredicted vs $29.44 at call
Conv.brain's confidence, 1–10
Driverwhy the brain put the point here
Prediction made
Sep 5, 2026
—
$29.44at call
—
—
The anchor — every point below is measured from this price and date.
2 weeks
Sep 19, 2026
$27.28–$31.60typical range · internal point $29.90
—
±7.3%
6/10
Risk-on regime and momentum press extend near-term bid
1 month
Oct 5, 2026
$26.32–$32.56typical range · internal point $30.20
Post-earnings drift, chemical demand concerns resurface
4 months
Jan 5, 2027
$25.40
—
-13.7%
5/10
Value gravity toward fair-value anchors accelerates
5 months
Feb 5, 2027
$24.20
—
-17.8%
5/10
Quality and forensic drags weigh through winter
6 months
Mar 5, 2027
$23.10
—
-21.5%
6/10
Converges toward deterministic baseline near 22.45
Why ranges on the short rungs?
A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here —
three prompt formulations all lost to simply predicting zero — while the stock's own
volatility scale (σ×√t) described those windows well. So the short rungs claim what's
actually knowable: the typical travel, with earnings timing flagged where the variance
will come from. The internal point calls keep being generated and graded to map where
real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.
Deterministic control (v0.3 value line) targets
$22.45
(-23.8%)
— both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it.
Brain: claude-opus-4-7.